Water Retention and Aquaporins in Heart Failure,Liver Disease and Pregnancy

Lee W.H. , Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257–67

Arroyo V. , Rodes J. , Gutierrez-Lizarraga M.A. , Revert L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976; 21: 249–56

Starling EH. On the absorption of fluid from the connective tissue spaces. J Physiol (Lond) 1896; 19: 312

Hope JA. A Treatise on the Diseases of the Heart and Blood Vessels. London: William Kid, 1832

Mackenzie J. Disease of the Heart, (3rd edn). London: Oxford University Press, 1913

Lieberman F.L. , Denison E.K. , Reynolds TB. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis; the overflow theory of ascites formation. Ann NY Acad Sci 1970; 170: 202–6

Papper S. The role of the kidney in Laennec's cirrhosis of the liver. Medicine 1958; 37: 299–316

Schrier R.W. , Durr J. Pregnancy: an overfill or underfill state. Am J Kidney Dis 1987; 9: 284–9

Szatalowicz V.L. , Arnold P.E. , Chaimovitz C. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Eng J Med 1981; 305: 263–6

Lolait S.J. , O'Carroll A.M. , McBride O.W. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 1992; 357: 336–9

Sasaki S. , Fushimi K. , Saito H. Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest 1994; 93: 1250–6

Yamamura Y. , Ogawa H. , Yamashita H. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol 1992; 105: 787–91

Inoue T. , Ohnishi A. , Matsuo A. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis. Clin Pharmacol Ther 1998; 63: 561–70

Schrier R.W. , Arroyo V. , Bernardi M. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hematology 1988; 8: 1151–7

Schrier RW. Pathogenesis of sodium and water retention in highoutput and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. First of two parts. N Engl J Med 1988; 319: 1065–72

Schrier RW. Pathogenesis of sodium and water retention in highoutput and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. Second of two parts. N Eng J Med 1988; 319: 1127–34

Pruszczynski W. , Vahanian A. , Ardaillou R. , Acar J. Role of antidiuretic hormone in impaired water excretion of patients with congestive heart failure. J Clin Endocrinol Metab 1984; 58: 599–602

Kim J.K. , Michel J-B , Soubrier F. Arginine vasopressin gene expression in chronic cardiac failure in rats. Kidney Int 1990; 38: 818–22

Xu D-L , Martin P-Y , Ohara M. Upregulation of aquaporin-2 water channel expression in chronic heart failure. J Clin Invest 1997; 99: 1500–5

Martin P-Y , Abraham W.T. , Xu L. Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol 1999; 10: 2165–70

Rai T. , Sekine K. , Kanno K. Urinary excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol 1997; 8: 1357–62

Bichet D. , Szatalowicz V. , Chaimovitz C. , Schrier RW. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med 1982; 96: 413–7

Kim J.K. , Summer S.N. , Howard R.L. , Schrier RW. Vasopressin gene expression in rats with experimental cirrhosis. Hepatology 1993; 17: 143–7

Aahina Y. , Izumi N. , Enomoto N. , Sasaki S. Increased gene expression of water channel in cirrhotic rat kidneys. Hepatology 1995; 21: 169–733

Fernandez-Llama P. , Jimenez W. , Bosch-Marce M. Dysregulation of renal aquaporins and Na-Cl cotransporter in CC14-induced cirrhosis. Kidney Int 2000; 58: 216–28

Claria J. , Jiminez W. , Arroyo V. , Guarner F. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats. Gastroenterology 1989; 97: 1294–9

Bosch-Marce M. , Poo J.L. , Jimenez W. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention. J Pharmacol Exp Therap 1999; 289: 194–201

Jimenez W. , Angeli P. , Leivas A. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention. Gastroenterology 1995; 109: 217–23

Moreau R. , Cailmail S. , Hamon G. , Lebrec D. Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis. J Gastroenterol Hepatol 1996; 11: 857–63

Niederberger M. , Martin P-Y , Gines P. , Morris K. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 1995; 109: 1624–30

Martin P-Y , Ohara M. , Gines P. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998; 101: 235–42

Durr J.A. , Stamoutsos B. , Lindheimer MD. Osmoregulation during pregnancy in the rat. Evidence for resetting of the threshold for vasopressin secretion during gestation. J Clin Invest 1981; 68: 337–46

Schrier R.W. , Briner VA. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol 1991; 77: 632–9

Ohara M. , Martin P-Y , Xu D-L Upregulation of aquaporin 2 water channel expression in pregnant rats. J Clin Invest 1998; 101: 1076–83

Chapman A.B. , Abraham W.T. , Zamudio S. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998; 54: 1056–63

Xu D-L , Martin P-Y , St. Jon J Upregulation of endothelial and neuronal constitutive nitric oxide synthase in pregnant rats. Am J Physiol 1996; 271: R1739–R1745

Cadnapaphornchai M.A. , Ohara M , Morris K.G. Jr. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol 2001; 280: F592–F598